29 Jul 2021 16:31
Ap24
AMENDMENT
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN ACLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 8 July 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
21,883(Loan Return)* 822,555 | N/A 10.7505 GBP | N/A 10.5550 GBP |
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
1,214,360 | 10.7500 GBP | 10.5550 GBP |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Long
Decrease Short
Increase Long
Increase Short
Opening a Short Position | 238 326
514 5,330 13,263 4,745 6,246 10,337 1,431 1,982 5,260 433,171 1,012 1,012 70,000 63,189
6,578 9 510 14,031 6,579 10,695 1,094
100,627 19,634 3,382 6,445 7,266 2,018 13,263 1,340 186 37,500 2,730 779 9 928 67,218 992
2,098 | 10.7201 GBP 10.7225 GBP
10.6700 GBP 10.6746 GBP 10.6894 GBP 10.7058 GBP 10.7079 GBP 10.7116 GBP 10.7150 GBP 10.7165 GBP 10.7171 GBP 10.7190 GBP 10.7247 GBP 10.7332 GBP 10.7489 GBP 10.7500 GBP
10.6863 GBP 10.6992 GBP 10.7154 GBP 10.7233 GBP 10.7264 GBP 10.7281 GBP 10.7463 GBP
10.6911 GBP 10.6983 GBP 10.7001 GBP 10.7071 GBP 10.7111 GBP 10.7127 GBP 10.7165 GBP 10.7201 GBP 10.7246 GBP 10.7252 GBP 10.7302 GBP 10.7351 GBP 10.7389 GBP 10.7418 GBP 10.7501 GBP 10.7505 GBP
10.7515 GBP |
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securitiesunder any option referred to on this form or relating to the voting rights or future acquisitionor disposal of any relevant securities to which any derivative referred to on this form is referenced.If none, this should be stated.
Date of disclosure | 29 July 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |